Schedule 13G ownership disclosure
Ginkgo Bioworks Holdings Inc
Class A Common Stock, $0.0001 par value per share · CUSIP: 37611X209
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Cascade Investment, L.L.C.
Shares: 3,621,636.00 · Class: 7.5%
- William H. Gates III
Shares: 3,621,636.00 · Class: 7.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-112557
- Form type
- SCHEDULE 13G/A
- Filer
- CASCADE INVESTMENT, L.L.C.
- CIK
- CIK 1052192
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership